Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway
Authors:
- Didrik F. VestrheimDVDidrik F. Vestrheim
- Øistein LøvollØLØistein Løvoll
- Ingeborg S. AabergeIAIngeborg S. Aaberge
- Dominique A. CaugantDCDominique A. Caugant
- E. Arne HøibyEHE. Arne Høiby
- Hilde BakkeHBHilde Bakke
- Marianne R. BergsakerMBMarianne R. Bergsaker
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization among Immunized and Unimmunized Children in a Community‐Randomized TrialThe Journal of Infectious Diseases, 2007
- Discovery of a New Capsular Serotype (6C) within Serogroup 6 ofStreptococcus pneumoniaeJournal of Clinical Microbiology, 2007
- Rapid Spread in Norway of an Erythromycin-Resistant Pneumococcal Clone, Despite Low Usage of MacrolidesMicrobial Drug Resistance, 2007
- Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate VaccineJAMA, 2005
- Systemic pneumococcal disease in Norway 1995–2001: capsular serotypes and antimicrobial resistanceEpidemiology and Infection, 2004
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Historical Changes in Pneumococcal Serogroup Distribution: Implications for the Era of Pneumococcal Conjugate VaccinesClinical Infectious Diseases, 2002
- Dynamics of Penicillin‐Susceptible Clones in Invasive Pneumococcal DiseaseThe Journal of Infectious Diseases, 2001
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part IClinical Infectious Diseases, 2000